查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1544120

经导管主动脉瓣置换术的全球市场

Transcatheter Aortic Valve Replacement Procedures
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球经导管主动脉瓣置换术市场预计将达到 183 亿美元

经导管主动脉瓣置换术的全球市场预计 2023 年为 73 亿美元，预计到 2030 年将达到 183 亿美元，2023-2030 年分析期间复合年增长率为 14.0%。经股动脉手术是本报告分析的细分市场之一，预计复合年增长率为 14.8%，到分析期结束时将达到 170 亿美元。在分析期间，锁骨下手术部分的复合年增长率估计为 7.4%。

美国市场预计20亿美元，中国预计复合年增长率13.0%

预计到 2023 年，美国经导管主动脉瓣置换术市场将达到 20 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达27亿美元，2023-2030年分析期间复合年增长率为13.0%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 12.9% 和 11.8%。在欧洲，德国的复合年增长率预计约为 9.9%。

全球经导管主动脉瓣置换术市场 - 主要趋势与驱动因素总结

什么是经导管主动脉瓣置换术以及为什么它很重要？

经导管主动脉瓣置换术(TAVR) 是一种微创手术，用于治疗严重主动脉瓣狭窄，即主动脉瓣变窄并限制心臟血流的情况。在 TAVR 手术中，通常会透过股动脉插入导管来更换瓣膜，因此不需要进行心臟直视手术。这些手术对于因年龄或合併症而面临传统主动脉瓣置换术(SAVR) 高风险的患者至关重要。 TAVR 提供了一种微创替代方案，恢復时间短，併发症低，使其成为改善主动脉瓣狭窄治疗患者预后的重要选择。

TAVR 手术如何改善病患的治疗效果？

TAVR 治疗透过为严重主动脉瓣狭窄提供更安全、侵入性较小的治疗方法来改善患者的预后。 TAVR 是微创手术，与传统的心臟直视手术相比，住院时间更短、恢復更快、疼痛更少。这种方法还可以最大限度地降低心臟直视手术中常见併发症的风险，例如感染疾病和出血。 TAVR 已被证明可以透过缓解主动脉瓣狭窄的症状（例如呼吸急促、疲劳和胸痛）来显着改善患者的生活品质。此外，TAVR 与较低的死亡率和改善的长期存活率相关，特别是对于不适合 SAVR 的高风险患者。

为什么 TAVR 手术的采用越来越多？

由于几个重要因素，TAVR 手术的采用正在增加。世界人口老化和主动脉瓣狭窄（尤其是老年人）盛行率的不断增加，增加了对有效治疗方案的需求。医疗技术和诊断影像技术的进步使 TAVR 手术更安全、更有效，使更多患者更容易接受。临床试验和研究表明 TAVR 相对于传统手术方法的优势也有助于其越来越受到医疗保健专业人员的认可。此外，下一代 TAVR 设备的开发以及扩大适应症以包括中度风险和低风险患者也支持了这些手术的采用。对改善患者预后和生活品质的关注进一步增加了对 TAVR 作为主动脉瓣狭窄首选治疗选择的需求。

推动 TAVR 手术市场成长的因素有哪些？

经导管主动脉瓣置换术市场的成长受到多种因素的推动。主动脉瓣狭窄的盛行率不断增加，特别是在人口老化中，对有效的治疗方案产生了巨大的需求。 TAVR 设备和手术的技术进步将提高这些手术的安全性和有效性，并促进其采用。临床证据支持 TAVR 优于传统手术方法，有助于其越来越受到医疗保健提供者和患者的接受。 TAVR 适应症的扩大，包括在中危险群和低危险群患者中的使用，正在进一步推动市场成长。对缩短恢復时间和改善患者治疗效果的微创手术的重视也推动了对 TAVR 的需求。此外，为改善 TAVR 技术和治疗效果而进行的持续研发工作，以及有利的报销政策，也为市场扩张做出了重大贡献。

受访企业范例（47家知名企业）

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Bracco SpA
  • Edwards Lifesciences Corporation
  • Jenavalve Technology, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP15285

Global Transcatheter Aortic Valve Replacement Procedures Market to Reach US$18.3 Billion by 2030

The global market for Transcatheter Aortic Valve Replacement Procedures estimated at US$7.3 Billion in the year 2023, is expected to reach US$18.3 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2023-2030. Transfemoral Procedure, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$17.0 Billion by the end of the analysis period. Growth in the Subclavian Procedure segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 13.0% CAGR

The Transcatheter Aortic Valve Replacement Procedures market in the U.S. is estimated at US$2.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 13.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.9% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.9% CAGR.

Global Transcatheter Aortic Valve Replacement Procedures Market - Key Trends & Drivers Summarized

What are Transcatheter Aortic Valve Replacement Procedures and Why are They Critical?

Transcatheter Aortic Valve Replacement (TAVR) Procedures are minimally invasive surgeries used to treat severe aortic stenosis, a condition where the aortic valve becomes narrowed, restricting blood flow from the heart. TAVR procedures involve the insertion of a replacement valve via a catheter, usually through the femoral artery, eliminating the need for open-heart surgery. These procedures are critical for patients who are at high risk for conventional surgical aortic valve replacement (SAVR) due to age or comorbid conditions. TAVR offers a less invasive alternative with shorter recovery times and reduced risk of complications, making it a vital option for improving patient outcomes in aortic stenosis treatment.

How Do TAVR Procedures Enhance Patient Outcomes?

TAVR Procedures enhance patient outcomes by providing a safer and less invasive treatment option for severe aortic stenosis. The minimally invasive nature of TAVR results in shorter hospital stays, faster recovery times, and reduced pain compared to traditional open-heart surgery. This approach also minimizes the risk of complications, such as infections and bleeding, which are more common in open-heart procedures. TAVR has shown to significantly improve the quality of life for patients by alleviating symptoms of aortic stenosis, such as shortness of breath, fatigue, and chest pain. Additionally, TAVR is associated with lower mortality rates and better long-term survival, particularly in high-risk patients who are not suitable candidates for SAVR.

Why is the Adoption of TAVR Procedures Increasing?

The adoption of TAVR Procedures is increasing due to several critical factors. The aging global population and the rising prevalence of aortic stenosis, particularly among the elderly, create a growing demand for effective treatment options. Advances in medical technology and imaging techniques have improved the safety and efficacy of TAVR procedures, making them more accessible to a broader patient population. Clinical trials and studies demonstrating the benefits of TAVR over traditional surgical approaches have also contributed to its growing acceptance among healthcare providers. Additionally, the development of next-generation TAVR devices and expanding indications for their use, including intermediate-risk and low-risk patients, are driving the adoption of these procedures. The focus on improving patient outcomes and quality of life further propels the demand for TAVR as a preferred treatment option for aortic stenosis.

What Factors are Driving the Growth of the TAVR Procedures Market?

The growth in the Transcatheter Aortic Valve Replacement Procedures market is driven by several factors. The increasing prevalence of aortic stenosis, particularly among the aging population, creates a significant demand for effective treatment options. Technological advancements in TAVR devices and procedural techniques enhance the safety and efficacy of these procedures, driving their adoption. Clinical evidence supporting the benefits of TAVR over traditional surgical approaches contributes to its growing acceptance among healthcare providers and patients. Expanding indications for TAVR, including its use in intermediate-risk and low-risk patients, further fuel market growth. The emphasis on minimally invasive procedures that offer faster recovery times and improved patient outcomes also drives the demand for TAVR. Additionally, ongoing research and development efforts to improve TAVR technology and outcomes, along with favorable reimbursement policies, significantly contribute to market expansion.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Bracco SpA
  • Edwards Lifesciences Corporation
  • Jenavalve Technology, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transcatheter Aortic Valve Replacement Procedures - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases
    • Growing Aging Population and Associated Heart Conditions
    • Advancements in TAVR Device Technology
    • Rising Adoption of Minimally Invasive Procedures
    • Expansion of Indications for TAVR Procedures
    • Integration of Imaging and Navigation Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Transcatheter Aortic Valve Replacement Procedures Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transfemoral Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Transfemoral Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Transfemoral Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Subclavian Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Subclavian Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Subclavian Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • JAPAN
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • CHINA
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • EUROPE
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • FRANCE
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • GERMANY
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Rest of Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Asia-Pacific 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of World 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030

IV. COMPETITION